[HTML][HTML] A comprehensive review on pharmacologic agents, immunotherapies and supportive therapeutics for COVID-19

K Sharun, R Tiwari, MI Yatoo, S Natesan, D Megawati… - Narra J, 2022 - ncbi.nlm.nih.gov
The emergence of coronavirus disease 2019 (COVID-19), caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), has affected many countries throughout …

COVID-19: An overview of the current pharmacological interventions, vaccines, and clinical trials

R Chakraborty, S Parvez - Biochemical pharmacology, 2020 - Elsevier
COVID-19, the greatest public health emergency of the 21st century, has affected 215
countries and territories around the world resulting in 15,151,738 confirmed cases and …

Potential therapeutic options for COVID-19: current status, challenges, and future perspectives

C Sarkar, M Mondal, M Torequl Islam… - Frontiers in …, 2020 - frontiersin.org
The COVID-19 pandemic represents an unprecedented challenge for the researchers to
offer safe, tolerable, and effective treatment strategies for its causative agent known as …

COVID-19 treatment options: a difficult journey between failed attempts and experimental drugs

A Bartoli, F Gabrielli, T Alicandro, F Nascimbeni… - Internal and emergency …, 2021 - Springer
Since its outbreak in China in December 2019 a novel Coronavirus, named SARS-CoV-2,
has spread worldwide causing many cases of severe pneumonia, referred to as COVID-19 …

Revisiting potential druggable targets against SARS‐CoV‐2 and repurposing therapeutics under preclinical study and clinical trials: A comprehensive review

AAM Sohag, MA Hannan, S Rahman… - Drug development …, 2020 - Wiley Online Library
Abstract Coronavirus disease‐19 (COVID‐19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS‐CoV‐2), is one of the most contagious diseases in human …

The race to treat COVID-19: Potential therapeutic agents for the prevention and treatment of SARS-CoV-2

I Ahmad - European journal of medicinal chemistry, 2021 - Elsevier
The unforeseen emergence of coronavirus disease 2019 (COVID-19), a severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) at the Wuhan province of China in …

Drug targets for COVID-19 therapeutics: Ongoing global efforts

A Saxena - Journal of biosciences, 2020 - Springer
The current global pandemic COVID-19 caused by the SARS-CoV-2 virus has already
inflicted insurmountable damage both to the human lives and global economy. There is an …

Potential repurposed SARS-CoV-2 (COVID-19) infection drugs

GEDA Abuo-Rahma, MFA Mohamed, TS Ibrahim… - RSC …, 2020 - pubs.rsc.org
The global outbreak of COVID-19 viral infection is associated with the absence of specific
drug (s) for fighting this viral infection. About 10 million people are already infected, about …

[HTML][HTML] Comprehensive analysis of drugs to treat SARS‑CoV‑2 infection: Mechanistic insights into current COVID‑19 therapies

GM Nitulescu, H Paunescu… - International …, 2020 - spandidos-publications.com
The major impact produced by the severe acute respiratory syndrome coronavirus 2 (SARS‑
CoV‑2) focused many researchers attention to find treatments that can suppress …

[HTML][HTML] COVID-19 challenges and its therapeutics

SU Rehman, SU Rehman, HH Yoo - Biomedicine & Pharmacotherapy, 2021 - Elsevier
Abstract COVID-19, an infectious disease, has emerged as one of the leading causes of
death worldwide, making it one of the severe public health issues in recent decades. nCoV …